1 Materials and Methods This
prospective,
16-site study of 2105 women (study period:
2 information, while frontal cortex codes for
prospective action.
3 ime MALDI-TOF MS pharmacist notification and
prospective AMS provider feedback.
4 In
prospective analyses, men in the highest tertile of suga
5 In a
prospective analysis of data acquired from four differen
6 Patients and Methods A
prospective and comprehensive flow cytometry-based immun
7 d at follow-up with all-cause mortality in a
prospective and consecutive cohort of patients discharge
8 erative posturing we were able to show, in a
prospective and ethically acceptable manner, that RD sta
9 njugated materials as solids is key to their
prospective applications, predictive power over these st
10 We introduce a new '
prospective'
aspect of agency and show that subliminally
11 res and detailed protocol with comprehensive
prospective assessment of health-related quality of life
12 We evaluated the
prospective association of arsenic exposure and metaboli
13 To study the
prospective association of CAC with risk of cardiovascul
14 ich we termed transient CMV infections, in a
prospective birth cohort of 30 highly exposed CMV-uninfe
15 etter understand possible determinants, this
prospective case series assesses gingival blood perfusio
16 We also did a
prospective case-control study to assess risk factors fo
17 A pilot study was conducted, followed by a
prospective case-control study.
18 ingle-cell chromatin accessibility can guide
prospective characterization of cancer heterogeneity.
19 Prospective,
classic twin study.
20 The aim of this
prospective clinical cohort study was to investigate the
21 CP-CRE and 69 non-CP isolates) as well as 45
prospective clinical isolates (15 CP-CRE and 30 non-CP-C
22 Prospective clinical registry with data collected from S
23 We established a large-scale,
prospective clinical sequencing initiative using a compr
24 This was a single-center
prospective clinical study including healthy heart trans
25 In a
prospective clinical trial of patients with HCV-CV, DAA-
26 Purpose To conduct a pilot
prospective clinical trial to evaluate the feasibility,
27 The objective of this
prospective clinical trial was to assess the influence o
28 tcomes for locally advanced NSCLC in a large
prospective clinical trial.
29 rapy-induced cardiotoxicity, suggesting that
prospective clinical trials are warranted to test this h
30 -1007, and others have entered or will enter
prospective clinical trials soon in several countries.
31 into hippocampal representations and support
prospective coding.
32 Of 2472 children enrolled in the
prospective cohort (1100 with acute otitis media; 705, g
33 l for 97% (342/351) of tumour samples in the
prospective cohort and showed 100% concordance with know
34 llected between June 2014 and November 2016;
prospective cohort data were collected from June 2016 to
35 his was a preplanned secondary analysis of a
prospective cohort enrolled from January 1 through Decem
36 This study was undertaken in a
prospective cohort in Norway to examine whether we could
37 d Their Later Development (CHYLD) Study is a
prospective cohort investigation of moderate to late pre
38 mortality.The UK Biobank study is an ongoing
prospective cohort of >0.5 million UK adults aged 40-69
39 Prospective cohort of 250 patients admitted to the ICU w
40 This is a cross-sectional analysis of a
prospective cohort of 26 probands with NAFLD-cirrhosis a
41 KOA in the Singapore Chinese Health Study, a
prospective cohort of 63,257 Chinese men and women, aged
42 data from the Black Women's Health Study, a
prospective cohort of AA women enrolled in 1995 and foll
43 Women's Health Initiative recruited a large
prospective cohort of postmenopausal women between 1993
44 ur findings from a large, well-characterized
prospective cohort provide compelling observational evid
45 (SSBs and weight change), a meta-analysis of
prospective cohort studies (type 2 diabetes), and a pros
46 ve fallen primarily into 2 broad categories:
prospective cohort studies and interventional trials.
47 ncer recurrence and mortality, yet data from
prospective cohort studies are limited.
48 tatus among 1,037 patients from two large US
prospective cohort studies diagnosed from 1986 to 2013.
49 9 adults participating in 2 population-based
prospective cohort studies from Europe (ESTHER) and the
50 We analysed data from 20
prospective cohort studies from ten countries (Iceland,
51 anguage randomized clinical trials (RCTs) or
prospective cohort studies that evaluated screening, stu
52 >/=4 RCTs were performed.Sixteen RCTs and 20
prospective cohort studies were included in the systemat
53 nducted a case-control study nested within 3
prospective cohort studies-the Melbourne Collaborative C
54 e older adults warrants replication in other
prospective cohort studies.
55 tive cohort studies (type 2 diabetes), and a
prospective cohort study (dental caries).
56 hort study assessing clinical outcomes and a
prospective cohort study assessing patient-centered outc
57 Prospective cohort study conducted in 5 ICUs in 3 hospit
58 A
prospective cohort study design was used to conduct the
59 The School Inner-City Asthma Study was a
prospective cohort study evaluating 284 students aged 4
60 kinson's Progression Markers Initiative is a
prospective cohort study evaluating progression markers
61 otocols and conventional care.We conducted a
prospective cohort study in adult elective colorectal re
62 This
prospective cohort study included 90 comatose patients w
63 This
prospective cohort study includes all ICU admissions fro
64 Data stemmed from CoLaus|PsyCoLaus, a
prospective cohort study including 35-66-year-old random
65 We conducted a
prospective cohort study of 189,793 men 40 y old or olde
66 n adverse events, we conducted a multicenter
prospective cohort study of 968 adults undergoing cardia
67 Prospective cohort study of adults undergoing LT for HCC
68 -uninfected TB patients and controls, and a
prospective cohort study of HIV-1-infected TB patients a
69 This was a multicenter
prospective cohort study of hospitals and private practi
70 We conducted a multicenter
prospective cohort study of infants (age <1 yr) hospital
71 Nationwide, registry-based,
prospective cohort study of patients admitted with acute
72 Longitudinal
prospective cohort study over 5 years of follow-up.
73 patients, and 15 control participants from a
prospective cohort study were included, which was approv
74 Prospective cohort study within the Comparison of Age-Re
75 In the
prospective cohort study, 1122 participants developed pa
76 In this
prospective cohort study, patients 70 years of age or ol
77 In a large
prospective cohort study, we evaluated the risk of breas
78 In this
prospective cohort study, we performed multiregion whole
79 We performed a
prospective cohort study.
80 We studied this issue in a large
prospective cohort study.
81 This is a
prospective cohort study.
82 Multicenter,
prospective cohort study.
83 Single-center
prospective cohort study.
84 Single-center,
prospective cohort, as well as secondary analysis of exi
85 21
prospective cohort, cross-sectional, and case-control st
86 iodontitis development in a population-based
prospective cohort.
87 enrolled in Right from the Start (2004-2010)
prospective cohort.
88 Using
prospective cohorts with chronic (n = 59) and acute (n =
89 In nested case-control analyses from two
prospective cohorts, carriers of CHIP had a risk of coro
90 ) were evaluated in 842 T2DM patients from 2
prospective cohorts.
91 ective structured interview at 2 years, with
prospective collection every 4 months thereafter, until
92 , meta-analyses, randomized clinical trials,
prospective comparative observational studies, and retro
93 Cross-sectional,
prospective,
comparative case series.
94 The PARADIGM-HF (
Prospective Comparison of ARNI With an ACE-Inhibitor to
95 d among children enrolled in a single-center
prospective consecutive cohort at The Children's Hospita
96 Prospective consecutive, interventional, comparative cas
97 A
prospective,
consecutive, observational case series.
98 We included 14 studies, 6 of which were
prospective,
covering a total of 4288419 men and women.
99 Prospective,
cross-sectional study.
100 Prospective,
cross-sectional, comparative instrument val
101 Prospective,
crossover, nonrandomized interventional stu
102 This represents the first
prospective data demonstrating a different response in o
103 Furthermore, currently no systematic,
prospective data exist regarding the optimal treatment a
104 Using
prospective data from the Early Determinants of Mammogra
105 Secondary analysis of
prospective data from the Randomized Evaluation of Sedat
106 Prospective data need to address whether specific change
107 of drug-induced liver injury enrolled into a
prospective database over a 10-year period that had unde
108 Retrospective review of a
prospective database.
109 In a second,
prospective dataset, the model detected 100% of 26 episo
110 hearing aid evaluation period (HAEP) using a
prospective design drawing on the health belief model an
111 Strengths include large sample size,
prospective design, and virtually complete follow-up; ho
112 tients treated at our institution on several
prospective dose-escalation trials.
113 Phase IIb global, multicenter, randomized,
prospective,
double-masked, controlled superiority trial
114 This
prospective,
double-masked, parallel-group, placebo-cont
115 The authors performed a
prospective economic substudy alongside the PEGASUS-TIMI
116 nt the pharmacodynamics of CO2 for MBF using
prospective end-tidal targeting to precisely control art
117 Using data from the
Prospective Epidemiological Risk Factor (PERF) Study (n
118 The evidence from
prospective epidemiological studies was quantitatively s
119 Some theories propose that
prospective evaluation involves a reactivation of the ne
120 We conducted a pragmatic multicenter
prospective evaluation of the use of point-of-care BLAST
121 months before enrollment and then documented
prospective exacerbations in each cohort.
122 Prospective exploration of the pattern of differences be
123 Yet, along the
prospective follow-up (3, 6, 12, and 24 mo), posttranspl
124 We used
prospective follow-up data from the UK Biobank cohort st
125 A
prospective follow-up study.
126 positron emission tomography after long-term
prospective follow-up.
127 Zeo-GO for detection of ketamine has immense
prospective for field-testing platforms.
128 A
prospective gastric cancer database identified 41 patien
129 In this large,
prospective,
genotype-phenotype study of ambulatory DCM
130 Prospective group comparison studies on representative c
131 RATIONALE: Improving the
prospective identification of patients with systemic inf
132 A
prospective,
international 1:1 randomized trial was cond
133 This
prospective interocularly controlled study was conducted
134 Prospective interventional study.
135 A
prospective,
interventional, nonrandomized study.
136 e optical coherence tomography (iOCT) in the
Prospective Intraoperative and Perioperative Ophthalmic
137 e clonal output of tumorigenic cells without
prospective isolation.
138 Prospective,
large-scale multicenter studies to validate
139 Using
prospective longitudinal epigenetic, neuroimaging and be
140 Using
prospective longitudinal populations of healthy children
141 A
prospective longitudinal study was conducted in a clinic
142 hildhood after preterm birth, we performed a
prospective,
longitudinal study of 587 preterm infants w
143 e of Cell Stem Cell,Lee et al. (2017) report
prospective markers of atrial versus ventricular myocyte
144 ticipated heterogeneity, favoring an ongoing
prospective matched-pair analysis of patients with simil
145 One mechanism that may support
prospective memory enhancements is the carry-over of emo
146 n to the development of PTSD symptoms in two
prospective military cohorts (one discovery and one repl
147 A
prospective,
multi-institutional randomized trial of SRS
148 We used a
prospective multicenter (Emory University Hospital, Brig
149 Materials and Methods This
prospective multicenter HIPAA-compliant study had instit
150 Materials and Methods In the
Prospective Multicenter Imaging Study for Evaluation of
151 In the PROMISE trial (
Prospective Multicenter Imaging Study for Evaluation of
152 This was a multinational
prospective multicenter observational study over 3 month
153 included from May 2009 to December 2014 in a
prospective multicenter registry.
154 Patients and Methods We performed a
prospective multicenter study of FDG-PET/CT scanning 12
155 Results of this large,
prospective multicenter U.S. study indicate that inabili
156 METHODS AND Subjects in the
prospective,
multicenter ADAPT-DES study (Assessment of
157 In a
prospective,
multicenter cohort study, we found that pat
158 Within this setting of a
prospective,
multicenter study with uniform GVHD prophyl
159 d and Marrow Transplantation, we conducted a
prospective,
multicenter, open-label, randomized phase I
160 In this
prospective,
multicenter, randomized, double-blind, plac
161 Prospective,
multisite, observational study following th
162 1 microperimeter as part of the multicenter,
prospective Natural History of the Progression of Atroph
163 severe combined immunodeficiency (SCID) to a
prospective natural history study.
164 Prospective,
noncomparative, consecutive interventional
165 Prospective observation study.
166 Prospective observational before-after cohort study.
167 This
prospective observational cohort study enrolled a consec
168 A
prospective observational cohort study in the ICU of two
169 This was a
prospective observational cohort study that included con
170 This
prospective observational cohort study was conducted at
171 A
prospective observational cohort study was conducted in
172 The APRICOT study was a
prospective observational multicentre cohort study of ch
173 We included randomized clinical trials and
prospective observational studies reporting visual acuit
174 We performed a multicenter
prospective observational study in 7 US academic institu
175 We performed a
prospective observational study in patients undergoing e
176 e in Restricting ICH Growth) is a preplanned
prospective observational study nested in the Antihypert
177 Prospective observational study of 424 trauma patients a
178 A
prospective observational study of preterm infants (birt
179 ateral breast cancer were recruited for this
prospective observational study.
180 Multicenter
prospective observational study.
181 Prospective observational trial with systematic dysphagi
182 We performed a
prospective,
observational clinical study to determine i
183 METHODS AND In the multicenter,
prospective,
observational PARIS study (Patterns of Non-
184 This multicenter,
prospective,
observational study of a quality improvemen
185 In this
prospective,
observational study performed from November
186 A
prospective,
observational study was carried out, includ
187 A
prospective,
observational study was conducted from Janu
188 A clinical,
prospective,
observational study was conducted in patien
189 Prospective open-label, unilateral single-dose, intravit
190 We did a multicentre,
prospective,
open-label, non-inferiority randomised clin
191 ing the generated models for the successful,
prospective optimization of crystallographically intract
192 We performed a
prospective phase I/II study to evaluate the sst recepto
193 emia (AML) was evaluated in 43 patients in a
prospective,
phase II trial.
194 ongitudinal Study of Parents and Children, a
prospective population-based cohort study of 14701 child
195 We performed a
prospective population-based cohort study.
196 Prospective,
population-based cohort analysis including
197 unprecedented range of apolipoproteins in a
prospective,
population-based study and relate their pla
198 Our
prospective pre-post study was conducted from June 2014
199 We did an international,
prospective,
randomised, open-label, blinded-endpoint tr
200 The lack of
prospective randomized clinical trials demonstrating tha
201 We conducted a
prospective randomized controlled trial to study the imp
202 Prospective randomized controlled trial.
203 This was a
prospective randomized crossover study in nonintubated p
204 This
prospective randomized multicenter trial provides eviden
205 ic antigen (PSA) response end points in five
prospective randomized phase III trials that enrolled a
206 Secondary analysis of data from the
prospective randomized Recompensation of Exacerbated Liv
207 This was a multicenter
prospective randomized trial including 143 patients with
208 al patient data meta-analysis of three large
prospective randomized trials in which sorafenib was the
209 Prospective,
randomized study.
210 This
prospective,
randomized trial found that treat and exten
211 We performed a
prospective,
randomized, controlled trial in nondiabetic
212 ophakic cystoid macular edema (PCME) using a
prospective,
randomized, double-masked, placebo-controll
213 Post hoc analysis of data from the 36-month
prospective,
randomized, FAME A and B trials.
214 Prospective,
randomized, multicenter, controlled clinica
215 This was a
prospective,
randomized, multicenter, single-blinded tri
216 his academic, single-center, parallel-group,
prospective,
randomized, open-label, blinded end point t
217 tional review board-approved, single-center,
prospective,
randomized, parallel-group, open-label trea
218 Prospective,
randomized, pilot study.
219 providing identifying information about the
prospective recipient (whose life was saved by the donat
220 t forms including environmental exposures in
prospective registries will likely provide further insig
221 tral valve prosthesis and were examined in a
prospective registry for short-term and 30-day outcomes.
222 From a
prospective registry of patients referred for coronary a
223 We established a
prospective registry to determine the risks associated w
224 D From December 2013 through October 2014, a
prospective,
replicate dosing, partially blinded, random
225 Plesiomonas shigelloides The study included
prospective,
retrospective, and prepared contrived speci
226 d in a case-control sample nested within the
prospective Salzburg Atherosclerosis Prevention Program
227 Among the 19
prospective samples submitted for PRNT, nine were negati
228 Prospective screening of the participants is under way.
229 Prospective single-center before and after study.
230 Prospective single-center observational cohort study.
231 We conducted a
prospective,
single-center cohort study, including 907 p
232 Prospective,
single-center, nonblinded, randomized contr
233 Patients and Methods A
prospective,
single-group, observational study design wa
234 Multicenter, randomized,
prospective,
single-masked trial.
235 ohort via prespecified analysis, blinded per
prospective-
specimen-collection, retrospective-blinded-e
236 suggesting it should be evaluated in future
prospective studies aimed at stratifying NAFLD-HCC risk.
237 Future
prospective studies are necessary to further characteriz
238 Prospective studies are needed to define the impact of p
239 Larger population-based,
prospective studies are required for better estimates of
240 Prospective studies evaluating cancer screening strategi
241 Importantly,
prospective studies evaluating whether screening program
242 There are no data from
prospective studies focused exclusively on patients with
243 portance of allergic rhinitis (AR), very few
prospective studies have been performed under conditions
244 Prospective studies have yielded mixed findings, and the
245 Prospective studies measuring high-sensitivity cardiac t
246 es, for which there is growing evidence from
prospective studies of beneficial effects on health.
247 in 377 children from the at-risk Copenhagen
Prospective Studies on Asthma in Childhood2000.
248 Most
prospective studies on the health effects of particulate
249 ed of PubMed, Web of Science, and EMBASE for
prospective studies published up to September 2016, repo
250 However, further large
prospective studies should be conducted to explore the c
251 been associated with obesity, there are few
prospective studies with objective measures.
252 The IMiD-14 model warrants evaluation in
prospective studies.
253 Results were compared to a
prospective study (N = 500, phase 1) performed prior to
254 In this observational
prospective study 63 patients undergoing binocular catar
255 in the US Drug-Induced Liver Injury Network
prospective study having a fatal outcome within 2 years
256 MATERIAL/This
prospective study included 50 patients referred for ultr
257 United Kingdom TTP registry, we undertook a
prospective study investigating the impact of the presen
258 ided the clinical influences associated with
prospective study involvement but was subject to attriti
259 We conducted a
prospective study involving 404 participants in KwaZulu-
260 A
prospective study is needed to investigate the effective
261 A larger
prospective study is required to establish the role of a
262 oral microbiota with EAC and ESCC risk in a
prospective study nested in two cohorts.
263 We performed a
prospective study of 13 patients with NERD, 11 patients
264 In a 20-year
prospective study of 1339 children with genetic risk fac
265 In a
prospective study of 2106 patients who underwent EMR for
266 We performed a multicenter
prospective study of 226 patients with hepatitis C virus
267 ical Risk Factor (PERF) Study (n = 2,103), a
prospective study of elderly women in Denmark, we found
268 nd analyzed data from 5766 participants in a
prospective study of long-term outcomes of pediatric pat
269 In a unique
prospective study of seventy participants referred with
270 We performed a
prospective study to determine the accuracy of (1)H-MRS
271 We performed a multicenter, observational,
prospective study under conditions of clinical practice.
272 Materials and Methods This
prospective study was approved by the ethics review boar
273 This cross-sectional
prospective study was conducted from March 1, 2014, to M
274 A
prospective study was conducted in Belgium during 2008-2
275 The aim of this
prospective study was for the first time to compare the
276 This
prospective study was part of the Melbourne Genomics Hea
277 ional review board-approved, HIPAA-compliant
prospective study, 158 subjects (43 subjects with normal
278 Materials and Methods In this
prospective study, 34 consecutive patients with multiple
279 In this
prospective study, 41 patients (16 women, 25 men; mean a
280 METHODS AND In this
prospective study, 88 consecutive ST-segment-elevation m
281 In this clinical
prospective study, data were collected including age, se
282 In this
prospective study, using an indoor wood-burning stove/fi
283 peratively as part of a multi-institutional,
prospective study.
284 rwent (68)Ga-DOTATOC PET/CT in a single-site
prospective study.
285 r-free patients, recruited through a 10-year
prospective study.
286 % specificity and 95% sensitivity of a blind
prospective study.
287 In this
prospective survey of referring physicians, we investiga
288 ears were measured for 940 children from the
prospective Swedish birth cohort BAMSE (Children, Allerg
289 f a cohort in the e-ROP Study (a multicenter
prospective telemedicine study) and the Postnatal Growth
290 Prospective testing is required to determine the clinica
291 Future
prospective testing, including additional dimensions of
292 Prospective time-to-pregnancy cohort study (2008 to date
293 A
prospective trial to validate this concept is warranted.
294 In a randomized
prospective trial, the imaging modalities were compared
295 Large
prospective trials are necessary to determine if these p
296 Larger
prospective trials are needed to define the optimal chem
297 n development and will require validation in
prospective trials.
298 ord blood nucleated cells in Project Viva, a
prospective U.S.-based prebirth cohort with relatively l
299 provide a proof of principle that can inform
prospective vaccine development not only for gonorrhoea
300 This study provides
prospective validation that functional connectivity betw